323 related articles for article (PubMed ID: 17148679)
21. Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway.
Thyrell L; Hjortsberg L; Arulampalam V; Panaretakis T; Uhles S; Dagnell M; Zhivotovsky B; Leibiger I; Grandér D; Pokrovskaja K
J Biol Chem; 2004 Jun; 279(23):24152-62. PubMed ID: 15056668
[TBL] [Abstract][Full Text] [Related]
22. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer.
Mita MM; Mita A; Rowinsky EK
Cancer Biol Ther; 2003; 2(4 Suppl 1):S169-77. PubMed ID: 14508096
[TBL] [Abstract][Full Text] [Related]
23. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
Miyata H; Chiang AC; Vinters HV
Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
[TBL] [Abstract][Full Text] [Related]
24. PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection.
Chong ZZ; Shang YC; Wang S; Maiese K
PLoS One; 2012; 7(9):e45456. PubMed ID: 23029019
[TBL] [Abstract][Full Text] [Related]
25. The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif.
Nojima H; Tokunaga C; Eguchi S; Oshiro N; Hidayat S; Yoshino K; Hara K; Tanaka N; Avruch J; Yonezawa K
J Biol Chem; 2003 May; 278(18):15461-4. PubMed ID: 12604610
[TBL] [Abstract][Full Text] [Related]
26. Mammalian target of rapamycin inhibition as therapy for hematologic malignancies.
Panwalkar A; Verstovsek S; Giles FJ
Cancer; 2004 Feb; 100(4):657-66. PubMed ID: 14770419
[TBL] [Abstract][Full Text] [Related]
27. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.
Chiarini F; Falà F; Tazzari PL; Ricci F; Astolfi A; Pession A; Pagliaro P; McCubrey JA; Martelli AM
Cancer Res; 2009 Apr; 69(8):3520-8. PubMed ID: 19351820
[TBL] [Abstract][Full Text] [Related]
28. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E.
Fingar DC; Richardson CJ; Tee AR; Cheatham L; Tsou C; Blenis J
Mol Cell Biol; 2004 Jan; 24(1):200-16. PubMed ID: 14673156
[TBL] [Abstract][Full Text] [Related]
29. Identification of a conserved motif required for mTOR signaling.
Schalm SS; Blenis J
Curr Biol; 2002 Apr; 12(8):632-9. PubMed ID: 11967149
[TBL] [Abstract][Full Text] [Related]
30. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
[TBL] [Abstract][Full Text] [Related]
31. Effects of simian virus 40 large and small tumor antigens on mammalian target of rapamycin signaling: small tumor antigen mediates hypophosphorylation of eIF4E-binding protein 1 late in infection.
Yu Y; Kudchodkar SB; Alwine JC
J Virol; 2005 Jun; 79(11):6882-9. PubMed ID: 15890927
[TBL] [Abstract][Full Text] [Related]
32. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
Kimball SR; Siegfried BA; Jefferson LS
J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
[TBL] [Abstract][Full Text] [Related]
33. Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells.
Ohguchi K; Banno Y; Nakagawa Y; Akao Y; Nozawa Y
J Cell Physiol; 2005 Dec; 205(3):444-51. PubMed ID: 15895362
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.
Huang S; Shu L; Easton J; Harwood FC; Germain GS; Ichijo H; Houghton PJ
J Biol Chem; 2004 Aug; 279(35):36490-6. PubMed ID: 15218033
[TBL] [Abstract][Full Text] [Related]
35. Roles of phosphatidylinositol 3'-kinase and mammalian target of rapamycin/p70 ribosomal protein S6 kinase in K-Ras-mediated transformation of intestinal epithelial cells.
Shao J; Evers BM; Sheng H
Cancer Res; 2004 Jan; 64(1):229-35. PubMed ID: 14729629
[TBL] [Abstract][Full Text] [Related]
36. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
[TBL] [Abstract][Full Text] [Related]
37. The mammalian target of rapamycin-p70 ribosomal S6 kinase but not phosphatidylinositol 3-kinase-Akt signaling is responsible for fibroblast growth factor-9-induced cell proliferation.
Wing LY; Chen HM; Chuang PC; Wu MH; Tsai SJ
J Biol Chem; 2005 May; 280(20):19937-47. PubMed ID: 15760907
[TBL] [Abstract][Full Text] [Related]
38. Intracellular parasitism with Toxoplasma gondii stimulates mammalian-target-of-rapamycin-dependent host cell growth despite impaired signalling to S6K1 and 4E-BP1.
Wang Y; Weiss LM; Orlofsky A
Cell Microbiol; 2009 Jun; 11(6):983-1000. PubMed ID: 19302577
[TBL] [Abstract][Full Text] [Related]
39. Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells.
Lal L; Li Y; Smith J; Sassano A; Uddin S; Parmar S; Tallman MS; Minucci S; Hay N; Platanias LC
Blood; 2005 Feb; 105(4):1669-77. PubMed ID: 15471950
[TBL] [Abstract][Full Text] [Related]
40. Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer.
Gao N; Zhang Z; Jiang BH; Shi X
Biochem Biophys Res Commun; 2003 Oct; 310(4):1124-32. PubMed ID: 14559232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]